PF-Atlas › Clinical Trials › AVID200-IPF

AVID200 TGF-b1/3 Selective Trap Phase II in IPF

AVID200 · TGF-b Trap · Phase 1/2

Registry ID
AVID200-IPF
Phase
Phase 1/2
Status
Recruiting
Drug / intervention
AVID200
Mechanism
TGF-b Trap
Sponsor
Formation Biologics
Start
2023-01

About this trial

AVID200 is evaluated in AVID200-IPF, a Phase 1/2 idiopathic pulmonary fibrosis study sponsored by Formation Biologics, targeting tgf-b trap. Current status: Recruiting.

View AVID200-IPF on ClinicalTrials.gov →

Explore related

All AVID200 trialsTGF-b Trap mechanismAll IPF trials
Medical disclaimer. This page summarizes public trial data for AVID200-IPF for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.